• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

BAP1/ASXL1 募集与激活以进行H2A去泛素化

BAP1/ASXL1 recruitment and activation for H2A deubiquitination.

作者信息

Sahtoe Danny D, van Dijk Willem J, Ekkebus Reggy, Ovaa Huib, Sixma Titia K

机构信息

Division of Biochemistry and Cancer Genomics Center, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands.

Division of Cell Biology II, Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, The Netherlands.

出版信息

Nat Commun. 2016 Jan 7;7:10292. doi: 10.1038/ncomms10292.

DOI:10.1038/ncomms10292
PMID:26739236
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4729829/
Abstract

The deubiquitinating enzyme BAP1 is an important tumor suppressor that has drawn attention in the clinic since its loss leads to a variety of cancers. BAP1 is activated by ASXL1 to deubiquitinate mono-ubiquitinated H2A at K119 in Polycomb gene repression, but the mechanism of this reaction remains poorly defined. Here we show that the BAP1 C-terminal extension is important for H2A deubiquitination by auto-recruiting BAP1 to nucleosomes in a process that does not require the nucleosome acidic patch. This initial encounter-like complex is unproductive and needs to be activated by the DEUBAD domains of ASXL1, ASXL2 or ASXL3 to increase BAP1's affinity for ubiquitin on H2A, to drive the deubiquitination reaction. The reaction is specific for Polycomb modifications of H2A as the complex cannot deubiquitinate the DNA damage-dependent ubiquitination at H2A K13/15. Our results contribute to the molecular understanding of this important tumor suppressor.

摘要

去泛素化酶BAP1是一种重要的肿瘤抑制因子,自其缺失会导致多种癌症以来,它在临床上受到了关注。在多梳基因抑制过程中,BAP1被ASXL1激活,以去除K119处单泛素化的H2A上的泛素,但该反应的机制仍不清楚。在这里,我们表明BAP1的C末端延伸对于H2A去泛素化很重要,它通过在一个不需要核小体酸性补丁的过程中自动将BAP1招募到核小体上。这种初始的类似相遇的复合物是无活性的,需要被ASXL1、ASXL2或ASXL3的DEUBAD结构域激活,以增加BAP1对H2A上泛素的亲和力,从而驱动去泛素化反应。该反应对H2A的多梳修饰具有特异性,因为该复合物不能去除H2A K13/15处依赖DNA损伤的泛素化。我们的结果有助于从分子层面理解这种重要的肿瘤抑制因子。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b72b/4729829/aed98b16753b/ncomms10292-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b72b/4729829/856730acbae1/ncomms10292-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b72b/4729829/10d8f5adbac4/ncomms10292-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b72b/4729829/bdb263110b1e/ncomms10292-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b72b/4729829/ccc7ba9798b8/ncomms10292-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b72b/4729829/e6a06d6f48eb/ncomms10292-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b72b/4729829/aed98b16753b/ncomms10292-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b72b/4729829/856730acbae1/ncomms10292-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b72b/4729829/10d8f5adbac4/ncomms10292-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b72b/4729829/bdb263110b1e/ncomms10292-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b72b/4729829/ccc7ba9798b8/ncomms10292-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b72b/4729829/e6a06d6f48eb/ncomms10292-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b72b/4729829/aed98b16753b/ncomms10292-f6.jpg

相似文献

1
BAP1/ASXL1 recruitment and activation for H2A deubiquitination.BAP1/ASXL1 募集与激活以进行H2A去泛素化
Nat Commun. 2016 Jan 7;7:10292. doi: 10.1038/ncomms10292.
2
The BAP1/ASXL2 Histone H2A Deubiquitinase Complex Regulates Cell Proliferation and Is Disrupted in Cancer.BAP1/ASXL2组蛋白H2A去泛素化酶复合物调控细胞增殖并在癌症中失调。
J Biol Chem. 2015 Nov 27;290(48):28643-63. doi: 10.1074/jbc.M115.661553. Epub 2015 Sep 28.
3
Structural basis of histone H2A lysine 119 deubiquitination by Polycomb repressive deubiquitinase BAP1/ASXL1.组蛋白 H2A 赖氨酸 119 去泛素化的结构基础由 Polycomb 抑制去泛素化酶 BAP1/ASXL1 完成。
Sci Adv. 2023 Aug 9;9(32):eadg9832. doi: 10.1126/sciadv.adg9832.
4
Familial and Somatic Mutations Inactivate ASXL1/2-Mediated Allosteric Regulation of BAP1 Deubiquitinase by Targeting Multiple Independent Domains.家族性和体细胞突变使 ASXL1/2 介导的 BAP1 去泛素化酶的变构调节失活,靶向多个独立结构域。
Cancer Res. 2018 Mar 1;78(5):1200-1213. doi: 10.1158/0008-5472.CAN-17-2876. Epub 2017 Dec 28.
5
Retracted: Histone H2B ubquitination regulates retinoic acid signaling through the cooperation of ASXL1 and BAP1.撤回声明:组蛋白 H2B 泛素化通过 ASXL1 和 BAP1 的合作调节视黄酸信号通路。
Mol Cell. 2013 Jul 25;51(2):200-10. doi: 10.1016/j.molcel.2013.06.005. Epub 2013 Jul 11.
6
BAP1 complex promotes transcription by opposing PRC1-mediated H2A ubiquitylation.BAP1 复合物通过拮抗 PRC1 介导的 H2A 泛素化促进转录。
Nat Commun. 2019 Jan 21;10(1):348. doi: 10.1038/s41467-018-08255-x.
7
Loss of BAP1 function leads to EZH2-dependent transformation.BAP1功能丧失导致EZH2依赖性转化。
Nat Med. 2015 Nov;21(11):1344-9. doi: 10.1038/nm.3947. Epub 2015 Oct 5.
8
Structural Basis for the Activation of the Deubiquitinase Calypso by the Polycomb Protein ASX.多梳蛋白 ASX 激活去泛素化酶 Calypso 的结构基础。
Structure. 2019 Mar 5;27(3):528-536.e4. doi: 10.1016/j.str.2018.11.013. Epub 2019 Jan 10.
9
Basis of the H2AK119 specificity of the Polycomb repressive deubiquitinase.多梳抑制去泛素化酶特异性识别 H2AK119 的基础。
Nature. 2023 Apr;616(7955):176-182. doi: 10.1038/s41586-023-05841-y. Epub 2023 Mar 29.
10
Kinetic Characterization of ASXL1/2-Mediated Allosteric Regulation of the BAP1 Deubiquitinase.ASXL1/2 介导的 BAP1 去泛素化酶别构调节的动力学特征。
Mol Cancer Res. 2021 Jul;19(7):1099-1112. doi: 10.1158/1541-7786.MCR-20-0080. Epub 2021 Mar 17.

引用本文的文献

1
Pleural mesothelioma.胸膜间皮瘤
Nat Rev Dis Primers. 2025 Aug 7;11(1):56. doi: 10.1038/s41572-025-00640-3.
2
ASXL1 mutation-related clonal hematopoiesis and age-related diseases: clinical evidence and molecular insights.ASXL1突变相关的克隆性造血与年龄相关疾病:临床证据与分子见解
Int J Hematol. 2025 Aug 7. doi: 10.1007/s12185-025-04038-5.
3
Polycomb Repressive-Deubiquitinase Complex Safeguards Oocyte Epigenome and Female Fertility by Restraining Polycomb Activity.多梳抑制去泛素化复合物通过抑制多梳活性来保护卵母细胞表观基因组和雌性生育能力。

本文引用的文献

1
The BAP1/ASXL2 Histone H2A Deubiquitinase Complex Regulates Cell Proliferation and Is Disrupted in Cancer.BAP1/ASXL2组蛋白H2A去泛素化酶复合物调控细胞增殖并在癌症中失调。
J Biol Chem. 2015 Nov 27;290(48):28643-63. doi: 10.1074/jbc.M115.661553. Epub 2015 Sep 28.
2
The E3 ubiquitin ligase activity of RING1B is not essential for early mouse development.RING1B的E3泛素连接酶活性对于小鼠早期发育并非必不可少。
Genes Dev. 2015 Sep 15;29(18):1897-902. doi: 10.1101/gad.268151.115.
3
Transcriptional repression by PRC1 in the absence of H2A monoubiquitylation.
bioRxiv. 2025 Jul 28:2025.07.24.666633. doi: 10.1101/2025.07.24.666633.
4
BAP1 Loss Affords Lipotoxicity Resistance in Uveal Melanoma.BAP1缺失赋予葡萄膜黑色素瘤抗脂毒性能力。
Pigment Cell Melanoma Res. 2025 May;38(3):e70021. doi: 10.1111/pcmr.70021.
5
Generation of site-specific ubiquitinated histones through chemical ligation to probe the specificities of histone deubiquitinases.通过化学连接生成位点特异性泛素化组蛋白以探究组蛋白去泛素化酶的特异性。
Front Epigenet Epigenom. 2023;1. doi: 10.3389/freae.2023.1238154. Epub 2023 Jul 30.
6
Colorectal cancer hot spot mutations attenuate the ASXL-MLL4 interaction.结直肠癌热点突变减弱了ASXL与MLL4的相互作用。
J Biol Chem. 2025 Mar;301(3):108333. doi: 10.1016/j.jbc.2025.108333. Epub 2025 Feb 19.
7
Deubiquitinases as novel therapeutic targets for diseases.去泛素化酶作为疾病的新型治疗靶点。
MedComm (2020). 2024 Dec 13;5(12):e70036. doi: 10.1002/mco2.70036. eCollection 2024 Dec.
8
A closer look at the role of deubiquitinating enzymes in the Hypoxia Inducible Factor pathway.深入探究去泛素化酶在缺氧诱导因子途径中的作用。
Biochem Soc Trans. 2024 Dec 19;52(6):2253-2265. doi: 10.1042/BST20230861.
9
Integrative multi-omics analysis reveals the role of tumor-associated endothelial cells and their signature in prognosis of intrahepatic cholangiocarcinoma.整合多组学分析揭示肿瘤相关内皮细胞及其特征在肝内胆管癌预后中的作用。
J Transl Med. 2024 Oct 19;22(1):948. doi: 10.1186/s12967-024-05750-2.
10
Epigenetic regulators of clonal hematopoiesis control CD8 T cell stemness during immunotherapy.表观遗传调控克隆性造血控制免疫治疗期间 CD8 T 细胞干性。
Science. 2024 Oct 11;386(6718):eadl4492. doi: 10.1126/science.adl4492.
在缺乏H2A单泛素化的情况下,PRC1介导的转录抑制作用
Genes Dev. 2015 Jul 15;29(14):1487-92. doi: 10.1101/gad.265439.115.
4
Cancer-associated ASXL1 mutations may act as gain-of-function mutations of the ASXL1-BAP1 complex.癌症相关的ASXL1突变可能作为ASXL1-BAP1复合物的功能获得性突变。
Nat Commun. 2015 Jun 22;6:7307. doi: 10.1038/ncomms8307.
5
Layers of DUB regulation.DUB 调控的多层次性。
Trends Biochem Sci. 2015 Aug;40(8):456-67. doi: 10.1016/j.tibs.2015.05.002. Epub 2015 Jun 11.
6
Structural basis for the activation and inhibition of the UCH37 deubiquitylase.泛素羧基末端水解酶37(UCH37)去泛素化酶激活与抑制的结构基础
Mol Cell. 2015 Mar 5;57(5):901-911. doi: 10.1016/j.molcel.2015.01.016. Epub 2015 Feb 19.
7
Mechanism of UCH-L5 activation and inhibition by DEUBAD domains in RPN13 and INO80G.RPN13和INO80G中DEUBAD结构域对UCH-L5的激活和抑制机制。
Mol Cell. 2015 Mar 5;57(5):887-900. doi: 10.1016/j.molcel.2014.12.039. Epub 2015 Feb 19.
8
Crystal structure of the PRC1 ubiquitylation module bound to the nucleosome.与核小体结合的PRC1泛素化模块的晶体结构。
Nature. 2014 Oct 30;514(7524):591-6. doi: 10.1038/nature13890.
9
Stabilization and targeting of INO80 to replication forks by BAP1 during normal DNA synthesis.在正常 DNA 合成过程中,BAP1 将 INO80 稳定并靶向复制叉。
Nat Commun. 2014 Oct 6;5:5128. doi: 10.1038/ncomms6128.
10
The forkhead transcription factor FOXK2 acts as a chromatin targeting factor for the BAP1-containing histone deubiquitinase complex.叉头转录因子FOXK2作为含BAP1的组蛋白去泛素化酶复合物的染色质靶向因子。
Nucleic Acids Res. 2014 Jun;42(10):6232-42. doi: 10.1093/nar/gku274. Epub 2014 Apr 19.